Biotechnology / Medical Research
GNI Group Ltd to Establish New Subsidiary to Fully Acquire Joint Venture Formed with EPS Corporation
GNI Group Ltd announced that it has decided to establish a new subsidiary in Hong Kong to fully acquire a joint venture, formed with EPS Corporation in China. The Company will hold at least 65% stake in the new subsidiary.
Karo Bio AB Extends Research Collaboration with Pfizer Inc
Karo Bio AB announced the extension of its existing research collaboration with Pfizer Inc on RORgamma modulators to the end of 2014. Pfizer will continue to provide full funding for the research costs. The collaboration that started in December 2011, aims to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases. Pfizer is responsible for all research costs of the project. Karo Bio is eligible to receive over USD 200 million in milestone payments in addition to any royalty fees.
Algeta ASA Opens Commercial Production Facility for Xofig
Algeta ASA announced that the Company has opened its commercial production facility for Xofig (radium Ra 223 dichloride) at the Institute for Energy Technology (IFE) in Kjeller, Norway. Xofigo is a particle-emitting radioactive therapeutic agent. It was approved by the US Food and Drug Administration (FDA) on May 15, 2013 for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral metastatic disease.
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  -0.01% |
| Basic Materials | -0.88% |
| Industrials | -0.61% |
| Cyclical Goods & Services |  +0.03% |
| Non-Cyclical Goods & Services | -0.23% |
| Financials | -0.23% |
| Healthcare | -0.43% |
| Technology | +0.04% |
| Telecoms | +0.08% |
| Utilities | -0.64% |
| DOW | 14,932.41 | -42.55 |
-0.28% |
| S&P 500 | 1,614.08 | -0.88 |
-0.05% |
| NASDAQ | 3,433.40 | -1.09 |
-0.03% |
| TR US Index | 146.52 | -0.13 |
-0.09% |
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
|
Provider: Edison Investment Research
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
